MX2012010852A - Deteccion temprana de cancer de mama recurrente, que utiliza el perfilado de metabolismo. - Google Patents
Deteccion temprana de cancer de mama recurrente, que utiliza el perfilado de metabolismo.Info
- Publication number
- MX2012010852A MX2012010852A MX2012010852A MX2012010852A MX2012010852A MX 2012010852 A MX2012010852 A MX 2012010852A MX 2012010852 A MX2012010852 A MX 2012010852A MX 2012010852 A MX2012010852 A MX 2012010852A MX 2012010852 A MX2012010852 A MX 2012010852A
- Authority
- MX
- Mexico
- Prior art keywords
- breast cancer
- metabolite
- identified
- gcxgc
- biomarkers
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 4
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 4
- 238000007884 metabolite profiling Methods 0.000 title abstract 2
- 230000000306 recurrent effect Effects 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- 238000005481 NMR spectroscopy Methods 0.000 abstract 3
- 239000000090 biomarker Substances 0.000 abstract 2
- 239000002207 metabolite Substances 0.000 abstract 2
- 238000012544 monitoring process Methods 0.000 abstract 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 238000007619 statistical method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/38—Flow patterns
- G01N30/46—Flow patterns using more than one column
- G01N30/461—Flow patterns using more than one column with serial coupling of separation columns
- G01N30/463—Flow patterns using more than one column with serial coupling of separation columns for multidimensional chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7206—Mass spectrometers interfaced to gas chromatograph
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/20—Oxygen containing
- Y10T436/200833—Carbonyl, ether, aldehyde or ketone containing
- Y10T436/201666—Carboxylic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31667910P | 2010-03-23 | 2010-03-23 | |
| PCT/US2011/029681 WO2011119772A1 (en) | 2010-03-23 | 2011-03-23 | Early detection of recurrent breast cancer using metabolite profiling |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012010852A true MX2012010852A (es) | 2013-04-03 |
Family
ID=44673604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012010852A MX2012010852A (es) | 2010-03-23 | 2011-03-23 | Deteccion temprana de cancer de mama recurrente, que utiliza el perfilado de metabolismo. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20130023056A1 (enExample) |
| EP (1) | EP2550533A4 (enExample) |
| JP (1) | JP2013522652A (enExample) |
| AU (1) | AU2011232434B2 (enExample) |
| CA (1) | CA2793735A1 (enExample) |
| MX (1) | MX2012010852A (enExample) |
| WO (1) | WO2011119772A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8653006B2 (en) | 2010-09-03 | 2014-02-18 | Purdue Research Foundation | Metabolite biomarkers for the detection of esophageal cancer using NMR |
| US20140162903A1 (en) * | 2012-10-31 | 2014-06-12 | Purdue Research Foundation | Metabolite Biomarkers For Forecasting The Outcome of Preoperative Chemotherapy For Breast Cancer Treatment |
| CN105451657A (zh) | 2013-03-15 | 2016-03-30 | 霍罗吉克公司 | 用于导航断层合成堆叠的包括自动聚焦的系统和方法 |
| EP3064940B1 (en) * | 2013-10-28 | 2019-07-03 | Salivatech Co., Ltd. | Salivary biomarker for pancreatic cancer |
| WO2015109263A2 (en) | 2014-01-17 | 2015-07-23 | University Of Washington | Biomarkers for detecting and monitoring colon cancer |
| BR112017004773B1 (pt) * | 2014-09-10 | 2024-02-27 | Fundação Pio Xii Hospital De Câncer De Barretos Cnpj/Mf | Biomarcadores para avaliação do câncer de mama |
| EP3262416B1 (en) * | 2015-02-27 | 2018-12-26 | Hosmotic SRL | Method for the diagnosis of endometrial carcinoma |
| JP6051257B2 (ja) * | 2015-04-15 | 2016-12-27 | ライオン株式会社 | 脂質異常症への罹患しやすさを試験する方法 |
| CN104991010B (zh) * | 2015-07-29 | 2017-10-13 | 中国药科大学 | 一种区分乳腺癌亚型生物标志物的组合物 |
| WO2017213246A1 (ja) * | 2016-06-10 | 2017-12-14 | 株式会社日立製作所 | 尿中代謝物による疾病診断法 |
| MX2019002918A (es) | 2016-09-16 | 2019-07-18 | Dyax Corp | Biomarcadores de metabolitos para enfermedades asociadas con el sistema de activacion por contacto. |
| WO2018183548A1 (en) | 2017-03-30 | 2018-10-04 | Hologic, Inc. | System and method for hierarchical multi-level feature image synthesis and representation |
| US11403483B2 (en) * | 2017-06-20 | 2022-08-02 | Hologic, Inc. | Dynamic self-learning medical image method and system |
| TWI716093B (zh) * | 2019-09-02 | 2021-01-11 | 高雄醫學大學 | 以代謝物標誌為基礎之預測乳癌復發風險的方法 |
| KR102283623B1 (ko) * | 2019-11-06 | 2021-07-30 | (의료)길의료재단 | 초음파 기법을 활용한 gc-ms 동시 분석 방법 |
| CN112630363A (zh) * | 2020-12-31 | 2021-04-09 | 四川大学华西医院 | 一种MXene生物响应特性代谢组学分析方法 |
| WO2025118084A1 (en) * | 2023-12-08 | 2025-06-12 | Biomark Cancer Systems Inc. | Early breast cancer detection using blood-based metabolomic profiling |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0727664A3 (en) * | 1995-02-15 | 1996-11-20 | Bayer Ag | Tumor markers to detect the recurrence of breast cancer |
| US20070221835A1 (en) * | 2006-03-06 | 2007-09-27 | Daniel Raftery | Combined Spectroscopic Method for Rapid Differentiation of Biological Samples |
| US20090075284A1 (en) * | 2006-09-19 | 2009-03-19 | The Regents Of The University Of Michigan | Metabolomic profiling of prostate cancer |
| BRPI0815095B1 (pt) * | 2007-07-17 | 2021-04-13 | Metabolon, Inc | Método de classificação de um indivíduo de acordo com a tolerância à glicose predita em tolerância à glicose normal (ngt), tolerância à glicose de jejum prejudicada (ifg), ou tolerância à glicose prejudicada (igt), para diabetes tipo 2, método de determinação da suscetibilidade de um indivíduo a diabetes tipo 2 e método de monitoramento da progressão ou regressão do pré- diabetes em um indivíduo |
| US8980637B2 (en) * | 2007-10-04 | 2015-03-17 | Purdue Research Foundation | Breast cancer biomarkers and identification methods using NMR and gas chromatography-mass spectrometry |
| CA2778226A1 (en) * | 2009-10-09 | 2011-04-14 | Carolyn Slupsky | Methods for diagnosis, treatment and monitoring of patient health using metabolomics |
| EP2488666A4 (en) * | 2009-10-13 | 2013-05-29 | Purdue Research Foundation | BIOMARKERS AND IDENTIFICATION METHOD FOR THE EARLY DETECTION AND PREDICTION OF THE REPRESENTATION OF BREAST CANCER BY NMR |
-
2011
- 2011-03-23 JP JP2013501439A patent/JP2013522652A/ja active Pending
- 2011-03-23 EP EP20110760174 patent/EP2550533A4/en not_active Withdrawn
- 2011-03-23 CA CA2793735A patent/CA2793735A1/en not_active Abandoned
- 2011-03-23 WO PCT/US2011/029681 patent/WO2011119772A1/en not_active Ceased
- 2011-03-23 AU AU2011232434A patent/AU2011232434B2/en not_active Ceased
- 2011-03-23 MX MX2012010852A patent/MX2012010852A/es unknown
-
2012
- 2012-09-21 US US13/624,042 patent/US20130023056A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011232434B2 (en) | 2013-11-21 |
| WO2011119772A1 (en) | 2011-09-29 |
| EP2550533A4 (en) | 2014-01-08 |
| US20130023056A1 (en) | 2013-01-24 |
| EP2550533A1 (en) | 2013-01-30 |
| JP2013522652A (ja) | 2013-06-13 |
| CA2793735A1 (en) | 2011-09-29 |
| AU2011232434A1 (en) | 2012-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012010852A (es) | Deteccion temprana de cancer de mama recurrente, que utiliza el perfilado de metabolismo. | |
| MX357550B (es) | Microarn plasmaticos para la deteccion de cancer colorrectal temprano. | |
| EP2566983A4 (en) | SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE | |
| Zheng et al. | Identification and validation of urinary metabolite biomarkers for major depressive disorder | |
| Hasim et al. | Revealing the metabonomic variation of EC using 1H-NMR spectroscopy and its association with the clinicopathological characteristics | |
| MX356986B (es) | Metodo para detectar aductos de nucleosomas. | |
| WO2014144129A3 (en) | Biomarkers and methods for predicting preterm birth | |
| BR112013003391B8 (pt) | Método para diagnosticar câncer pancreático em um indivíduo | |
| MX352035B (es) | Dispositivos, metodos y equipos de prueba para el analisis electronico de analitos. | |
| EP4455309A3 (en) | Methods for analysing nucleic acid sequence information using gc bias, optionally for detecting fetal nucleic acid abnormalities | |
| MX363201B (es) | Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico. | |
| NZ712746A (en) | Methods and systems for assessing clinical outcomes | |
| WO2013062931A3 (en) | A molecular beacon based assay for the detection of biomarkers of breast cancer metastasis | |
| WO2010099137A3 (en) | In situ methods for monitoring the emt status of tumor cells in vivo | |
| IN2014CN01787A (enExample) | ||
| EP3751283A3 (en) | Blood-based screen for detecting neurological diseases in primary care settings | |
| NZ629703A (en) | Methods and compositions for detecting multiple analytes with a single signal | |
| WO2014143977A3 (en) | Biomarkers and methods for predicting preeclampsia | |
| WO2013004852A3 (en) | Magnetic bead aggregation assay system and method for analysing and characterising magnetic bead aggregation and detection of target analytes | |
| US20210405053A1 (en) | Method for providing diagnostic information for biliary tract cancer and apparatus for diagnosing biliary tract cancer | |
| MX2012007009A (es) | Método para diagnosticar un tumor maligno. | |
| EP3775906A1 (en) | Metabolite-based breast cancer detection and diagnosis | |
| Zhang et al. | Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance | |
| BR112022011674A2 (pt) | Biblioteca de micropartículas pré-fabricadas e suas precursoras | |
| SG11201811433TA (en) | Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method |